After YAP1 was knocked down, increased migration capacity induced by miR-92 was partly impaired, indicated that the pro-tumor effect of miR-92 partly relies on the LATS2/YAP1 pathway (Figure 3G). The gene discussed is LATS2; the disease is neoplasm.